The historic rise of Viagra has long been a example of pharmaceutical success, however its legacy within the broader market now presents questions about potential yields . Alternative versions are diminishing patent protection , leading to anxieties that betting on companies heavily reliant to Viagra's once-dominant influence could be a speculative